Results 151 to 160 of about 1,765,540 (254)

A generic non-invasive neuromotor interface for human-computer interaction. [PDF]

Nature
Kaifosh P, Reardon TR, CTRL-labs at Reality Labs.   +2 more
europepmc   +1 more source

Research on the Perceived Quality of Virtual Reality Headsets in Human-Computer Interaction. [PDF]

Sensors (Basel), 2023
Yang Y, Zhong L, Li S, Yu A.
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Identifying Influential Theories in Human-Computer Interaction Within Health Informatics: A Systematic Review. [PDF]

Health Sci Rep
Mohammadzadeh N, Lotfi F, Samadpour H.
europepmc   +1 more source

Retracted: Role of Human-Computer Interaction Healthcare System in the Teaching of Physiology and Medicine. [PDF]

Comput Intell Neurosci, 2023
Intelligence And Neuroscience C.
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

ArecaNet: Robust Facial Emotion Recognition via Assembled Residual Enhanced Cross-Attention Networks for Emotion-Aware Human-Computer Interaction. [PDF]

Sensors (Basel)
Kim J, Choi G.
europepmc   +1 more source

Application of human-computer interaction virtual reality technology in urban cultural creative design. [PDF]

Sci Rep, 2023
Han S, Liu S, Ren L.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Human-Computer Interaction in Healthcare: A Bibliometric Analysis with CiteSpace. [PDF]

Healthcare (Basel)
Zhao X, Zhang S, Nan D, Han J, Kim JH.
europepmc   +1 more source